A community recommendation to wear surgical masks, with 50 masks and instructions supplied,
does it really help with Reduced SARS-CoV-2 infection in the wearer at one month?
research showsGrade D. The DANMASK-19 primary endpoint occurred in 42/2,392 (1.8%) versus 53/2,470 (2.1%): absolute difference -0.3 percentage points (95% CI -1.2 to 0.4), P=.38; OR 0.82 (0.54 to 1.23), P=.33. The trial did not test source control, mask mandates, or transmission to other people.
ads claimThese findings cannot be extended to source control, mask mandates, healthcare settings, or other epidemic conditions. The trial addressed protection of the wearer only.
Useful facts when choosing a product
- The intervention supplied 50 surgical masks and instructions.
- Community mask use was uncommon in Denmark in 2020.
- Follow-up lasted one month.
What the research actually shows
DANMASK-19 randomized 6,024 adults, 3,030 to a mask recommendation and 2,994 to control. The intervention supplied 50 surgical masks and instructions, while both groups followed prevailing public-health advice. The primary complete-case analysis included 4,862/6,024, leaving 19.3% missing. The Salling Foundations funded the investigator-led Rigshospitalet study. Masks were supplied within the study; manufacturer donation, medical writing, or publication support was not identified. NCT04337541 was first posted on 8 April 2020, six days after the 2 April start.
Why this is classified as D (34)
The wearer's-infection primary endpoint was null, but the interval retained benefit and harm and the trial had three design limitations, giving D with 34 points.
Counterpoint. This is not evidence that masks cause no discomfort or skin irritation, and it does not assess transmission from the wearer.
Rejudgment record. Cross-check applied — Null wearer-infection primary endpoint, wide confidence interval, complete-case analysis, 19.3% missingness, and one-month follow-up
| Endpoint | H | Hard endpoint - actual events such as death |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E0 | Null |
| Precision | C0 | The confidence interval leaves room for benefit |
The scoring table and the verdict agree (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Reduced infection in the wearer at one month | D | The result was null, OR 0.82 (0.54 to 1.23). |
| Reduced transmission to other people | ? | This was not measured by the trial. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Study 1 | Nationwide unblinded randomized controlled trial | 2,470 | Salling Foundations funding; investigator-led at Rigshospitalet | SARS-CoV-2 infection in the wearer at one month by antibody testing, PCR, or hospital diagnosis | 42/2,392 (1.8%) vs 53/2,470 (2.1%); difference -0.3 points (-1.2 to 0.4), P=.38; OR 0.82 (0.54 to 1.23), P=.33 | Single large randomized trial of infection in the wearer |
Receipt — 1 References
All 1 cited sources were verified for existence at the original page (as of 2026-08-26).
Final verification and publication gate: Codex · Verification cutoff: 2026-08-26 · Corrections: none
Cite this verdict
[Chamgap] No Benefit of a Surgical-Mask Recommendation for the Wearer's Own One-Month COVID-19 Infection — Evidence Grade D·34. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/immunity/surgical-mask-recommendation-wearer-covid-infection/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.